/

CDIO

Cardio Diagnostics Holdings IncClosed

1.75−0.03 −1.69%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 1.88 +7.43%

Open

1.86

Prev close

1.78

Day range

1.751.86

52-week range

0.97007.91

Volume

19.74K0.34×

Mkt cap

5.18M

P/E ttm

—

Fwd P/E

-7.00

EPS ttm

-2.86

Div yield

0.00%

Earnings

—

From 52w high

−77.88%

Price Chart

Yahoo Finance · delayed

CDIOOct 13, 2026O 1.86H 1.86L 1.75C 1.75−0.03 (−1.69%)Vol 19.80K

SMA 501.92
SMA 2002.13

1Y change −60.54% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

CDIO Cardio Diagnostics Holdings Inc · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −12.50%
1 month: −13.79%
3 months: −2.78%
6 months: −8.85%
Year to date: −35.42%
1 year: −60.54%

Valuation & ownership

Market cap: 5.18M
Enterprise value: −37.93K
P/E (ttm): —
Forward P/E: -7.00
PEG ratio: —
Price / book: 0.70
Price / sales (ttm): 358.41
EV / EBITDA: 0.01
EPS (ttm): -2.86
EPS (forward): -0.2500
Beta (5y monthly): 2.24
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 2.96M
Float: 2.84M
Short % of float: 0.03%
Short ratio (days): 0.03
Held by insiders: 8.31%
Held by institutions: 6.52%
Avg volume (3m): 57.24K
50-day average: 1.92
200-day average: 2.14
52-week change: −60.54%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 37.6
vs 50-day SMA: −9.00%
vs 200-day SMA: −17.73%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 7.69%
Realised vol (20d, ann.): 42.2%
From 52-week high: −77.88%
From 52-week low: +80.41%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): 14.45K
Revenue growth (yoy): −28.30%
Earnings growth (yoy): —
Gross margin: 100.00%
Operating margin: -27950.50%
Profit margin: 0.00%

DES

About Cardio Diagnostics Holdings Inc

Yahoo Finance profile

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Sector: Healthcare
Industry: Biotechnology
Employees: 15
Headquarters: Chicago, IL, United States
Website: cdio.ai
Officers: Dr. Meeshanthini V. Dogan Ph.D. Co-Founder, CEO & Director
Ms. Elisa Michael Luqman Esq., J.D., M.B.A. CFO & Principal Accounting Officer

SEAS

Seasonality · CDIO

2022–2026 · monthly returns

Strongest month Nov +133.29%Weakest month May −25.80%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-44.3	333.8	-70.2	-8.2	5.6	15.9	-28.8	19.9	1.6	-7.9			−35.4%
2025	-52.1	2.3	-26.5	28.8	-68.7	-9.8	15.0	-8.0	5.2	0.7	-28.7	-5.9	−90.1%
2024	-12.4	-25.7	-12.3	-51.8	1.2	-20.6	-18.2	-16.7	-40.5	25.6	8.6	201.6	−63.2%
2023	-9.4	259.4	13.3	-40.7	-35.8	-20.1	1.7	-54.5	-38.2	-11.2	575.5	22.1	+134.9%
2022		0.2	0.3	0.2	0.1	0.1	0.5	0.2	0.4	-71.7	-22.2	-52.0	−89.2%

13F

Investors Holding CDIO

latest 13F filings of 29 followed managers

Investors holding CDIO
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$107.7K	0.00%	49.20K	+221%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

CDIO

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

CDIO

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Cardio Diagnostics Holdings Inc

Seasonality · CDIO

Insider Activity · CDIO

Congress Trades · CDIO

Investors Holding CDIO

Investors Holding CDIO

Congress Trades · CDIO

Insider Activity · CDIO

Seasonality · CDIO

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Cardio Diagnostics Holdings Inc

Earnings & Dividends

News